This schedule includes recommendations in effect as of January 1, 2017. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consult the relevant Advisory Committee on Immunization Practices (ACIP) statement for detailed recommendations, available online at http://www.cdc.gov/vaccines/hcp/acip recs/index.html. Clinically significant adverse events that follow vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS) online(http://www.vaers.hhs.gov) or by telephone (800-822-7967). Suspected cases of vaccinepreventable diseases should be reported to the state or local health department. Additional information, including precautions and contraindications for vaccination, is available from CDC online (http://www.cdc.gov/vaccines/hcp/admin/ contraindications.html) or by telephone (800-CDC-INFO [800-232-4636]
PharmD Info is an online forum portal which connects all the Indian Pharmacy fraternities to share and discuss various professional related topics with other members of the site and it also focuses on creating a good communication platform on the web for the Indian pharmacists to develop their networks within the profession and with other healthcare professionals to enhance their knowledge,skills and professional relationships to serve better for our society.